Dexmedetomidine during suprazygomatic maxillary nerve block for pediatric cleft palate repair, randomized double-blind controlled study.
Conclusions: Addition of dexmedetomidine 0.5 µg/kg to bupivacaine 0.125% has accentuated the analgesic efficacy of bilateral suprazygomatic maxillary nerve block in children undergoing primary cleft palate repair with less postoperative supplemental analgesia or untoward effects.
PMID: 31888322 [PubMed]
Source: Korean Journal of Pain - Category: Anesthesiology Tags: Korean J Pain Source Type: research
More News: Anesthesiology | Cardiology | Children | Cleft Palate | Gastroschisis Repair | Heart | Pain | Pediatrics | Respiratory Medicine | Sinusitis | Study